Kiani Joe E reported option exercise involving 698 derivative units of IRADIMED CORP at $0.00 for $0 on Sep 23, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Sep 25, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
698Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,397Direct
Trade date
Sep 23, 2026Option exercise
Filed
Sep 25, 2026, 4:45 PM ET2-day reporting delay
Accession
0001228621-26-000003Code M · Transaction 229858
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 23, 2026Option exercise698——Trade 229857
2 transaction rows in this filing. Joint filers share the same rows.

IRMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IRMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +1.7%1w ago −3.7%1d ago +0.9%
Returns since7d −0.4%30d +0.1%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2: The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on September 23, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.